ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651851 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651851; 2) Community: the network communities that were significantly associated with the response to NSC 651851; 3) Molecule: the relationships between components within communities and NSC 651851; 4) MDR: the compounds that were significantly associated with the NSC 651851.

NSC Compound Enrichment Correlation
NSC 703763 Null 0.00166561193816139 0.34418197
NSC 72151 2H-1-Benzopyran-2-one, 6-[[4-[bis[2-[(methylsulfonyl)ethyl]amino]phenyl]methylene]amino]- (9CI) 0.00166561193816139 0.50290907
NSC 95382 Camptothecin Derivative 0.00166561193816139 0.58498373
NSC 166641 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 7-fluoro-2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride 0.0016656119381614 0.4887438
NSC 195327 4-APPT 0.00180188182321727 0.30689192
NSC 635544 Null 0.00180188182321727 -0.25228609
NSC 642329 Naphtho[2,3-c]furan-1(9a)-one, 3,3a,4,9-tetrahydro-4- (4-fluorophenyl)-6,7-dimethoxy-9-(4-hydroxy-3,5- dimethoxyphenyl)- 0.00180188182321727 0.7826535
NSC 94600 Camptothecin 0.00180188182321727 0.50950765
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.00182957917645006 0.46838496
NSC 648114 ANTINEOPLASTIC-D648114 0.00182957917645006 0.628573
Total:52  Current:3    [First] [Prev] [Next] [Last]